Can Europe's Organ Preservation Market Keep Pace with Its Transplant Revolution?

European transplant coordinators face an extraordinary paradox. More organs are being donated and transplanted than ever before—Spain achieved a record 6,464 organ transplants in 2024, a 10 per cent increase over the previous year, attaining the world's highest deceased donor rate of 52.6 per million population. Yet thousands of patients remain on waiting lists across the continent, their lives hanging in the balance while suitable organs are located and transported. The gap between donation and successful transplantation often comes down to a single, critical factor: preservation. The Europe organ preservation market is emerging as the essential enabler of this life-saving enterprise. Valued at USD 76.98 million in 2025, the market is projected to reach USD 119.93 million by 2034, growing at a compound annual rate of 5.05 per cent from 2026 to 2034. These figures reflect an industry at the heart of European healthcare's most profound transformation.

What's Driving Growth of Europe's Organ Preservation Market?

The rising prevalence of chronic organ failures is creating sustained demand for transplantation. The increasing prevalence of chronic diseases leading to end-stage organ failure across Europe is a primary driver for the organ preservation market. As conditions such as diabetes, hypertension, and liver disease progress to organ failure, transplantation becomes the only life-saving intervention, necessitating reliable preservation solutions.

Advancements in preservation technologies are enabling extended organ viability. Machine perfusion systems are revolutionising how organs are preserved, allowing extended viability and improved transplant outcomes. Normothermic machine perfusion is gaining traction alongside traditional cold storage methods, offering the potential to assess organ function before transplantation and reduce the risk of complications.

Government initiatives and regulatory frameworks are expanding donor pools. Comprehensive organ donation legislation, including opt-out consent systems, is being implemented across European nations to expand donor pools and address waiting list backlogs. These policy interventions are directly translating into more organs requiring preservation, driving sustained market growth.

Europe's advanced healthcare infrastructure and commitment to transplantation excellence provide a stable foundation. The region's sophisticated transplant networks, coordinated organ-sharing organisations, and commitment to healthcare innovation underpin consistent demand for preservation solutions. This institutional support creates a predictable environment for investment and innovation.

Three Trends Reshaping the Industry

Machine perfusion is challenging static cold storage as the preservation gold standard.

Static cold storage technique currently dominates the market with a 45.07 per cent share in 2025, attributed to its simplicity, cost-effectiveness, and established clinical protocols. However, technological innovations such as normothermic and hypothermic machine perfusion are gaining significant traction. These advanced techniques allow organs to be maintained in a more physiological state, potentially reducing ischaemic damage and improving post-transplant outcomes.

Why it matters: Machine perfusion could dramatically expand the pool of transplantable organs by making marginal organs viable.
Business implication: Manufacturers must invest in perfusion technology development to capture the high-growth segment.
Future impact: As perfusion systems become more cost-effective and clinically validated, they will likely erode static cold storage's dominance.

Artificial intelligence is transforming organ viability assessment.

The integration of artificial intelligence in organ viability assessment is positioning the market for continued expansion throughout the forecast period. AI algorithms can analyse perfusion data, biomarker profiles, and imaging to predict transplant outcomes with unprecedented accuracy, enabling clinicians to make better-informed decisions about organ utilisation.

Why it matters: AI-driven assessment reduces the risk of transplant failure and improves patient outcomes.
Business implication: Companies that develop AI-integrated preservation platforms will gain a significant competitive advantage.
Future impact: AI could enable real-time organ monitoring during transport, optimising preservation conditions dynamically.

Opt-out legislation is expanding the donor pool across Europe.

Deceased organ donation leads the market with a share of 74.05 per cent in 2025, reflecting the predominant role of post-mortem organ procurement in meeting transplant demand. Expanding opt-out legislation across European nations and improved donation coordination systems are strengthening this segment's contribution to overall transplant activities. Spain's record of 6,464 transplants in 2024 demonstrates what is possible with comprehensive donation systems.

Why it matters: Larger donor pools translate directly into increased demand for preservation solutions.
Business implication: Preservation solution and equipment suppliers must scale capacity to meet growing volumes.
Future impact: As more countries adopt opt-out systems, the pressure to develop longer-duration preservation technologies will intensify.

What the Market Numbers Actually Tell Us

A market expanding from USD 76.98 million to USD 119.93 million over nine years suggests significantly greater commercial activity across preservation solution manufacturers, equipment suppliers, transplant centres, and organ banks. The 5.05 per cent compound annual growth rate signals steady, sustainable expansion driven by demographic trends, technological innovation, and policy support. For investors and industry participants, this trajectory indicates that organ preservation is becoming an increasingly critical component of European healthcare infrastructure. Organ banks lead the end-user segment with a 45.09 per cent share in 2025, reflecting their central role in organ procurement, preservation, and distribution networks. The robust infrastructure of European organ sharing organisations and their coordinated allocation systems underpin this market dominance.

Where New Opportunities Are Emerging

The most significant opportunities lie at the intersection of technological innovation and policy expansion. The UW solution dominates the preservation solution market with a 35.86 per cent share in 2025, owing to its proven effectiveness in reducing cellular injury and extending organ viability during cold storage. However, next-generation preservation solutions are being developed alongside machine perfusion technologies, creating opportunities for companies that can demonstrate superior outcomes. Kidney preservation represents the largest organ-type segment with a 33.95 per cent market share in 2025, driven by the high prevalence of chronic kidney disease affecting millions of Europeans. Companies that can navigate the regulatory landscape, secure clinical validation, and build partnerships with transplant centres are well-positioned to capture value in this evolving market. Key players are investing in advanced perfusion technologies, expanding preservation solution portfolios, and strengthening distribution partnerships with transplant centres across Europe.